p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress

被引:109
作者
Charrier-Savournin, FB
Château, MT
Gire, V
Sedivy, J
Piette, J
Dulic, V [1 ]
机构
[1] CRBM, FRE 2593, F-34293 Montpellier, France
[2] Univ Montpellier 1, Fac Pharm, F-34060 Montpellier, France
[3] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Div Biol & Med, Providence, RI 02912 USA
[4] INSERM, Ctr Rech Cancerol, EMI0229, Montpellier, France
关键词
D O I
10.1091/mbc.E03-12-0871
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
G2 arrest of cells suffering DNA damage in S phase is crucial to avoid their entry into mitosis, with the concomitant risks of oncogenic transformation. According to the current model, signals elicited by DNA damage prevent mitosis by inhibiting both activation and nuclear import of cyclin B1-Cdk1, a master mitotic regulator. We now show that normal human fibroblasts use additional mechanisms to block activation of cyclin B1-Cdk1. In these cells, exposure to nonrepairable DNA damage leads to nuclear accumulation of inactive cyclin B1-Cdk1 complexes. This nuclear retention, which strictly depends on association with endogenous p21, prevents activation of cyclin B1-Cdk1 by Cdc25 and Cdk-activating kinase as well as its recruitment to the centrosome. In p21-deficient normal human fibroblasts and immortal cell lines, cyclin B1 fails to accumulate in the nucleus and could be readily detected at the centrosome in response to DNA damage. Therefore, in normal cells, p21 exerts a dual role in mediating DNA damage-induced cell cycle arrest and exit before mitosis. In addition to blocking pRb phosphorylation, p21 directly prevents mitosis by inactivating and maintaining the inactive state of mitotic cyclin-Cdk complexes. This, with subsequent degradation of mitotic cyclins, further contributes to the establishment of a permanent G2 arrest.
引用
收藏
页码:3965 / 3976
页数:12
相关论文
共 48 条
[21]   14-3-3σ is a p53-regulated inhibitor of G2/M progression [J].
Hermeking, H ;
Lengauer, C ;
Polyak, K ;
He, TC ;
Zhang, L ;
Thiagalingam, S ;
Kinzler, KW ;
Vogelstein, B .
MOLECULAR CELL, 1997, 1 (01) :3-11
[22]   Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells [J].
Hirota, T ;
Kunitoku, N ;
Sasayama, T ;
Marumoto, T ;
Zhang, DW ;
Nitta, M ;
Hatakeyama, K ;
Saya, H .
CELL, 2003, 114 (05) :585-598
[23]   Active cyclin B1-Cdk1 first appears on centrosomes in prophase [J].
Jackman, M ;
Lindon, C ;
Nigg, EA ;
Pines, J .
NATURE CELL BIOLOGY, 2003, 5 (02) :143-148
[24]   Nuclear localization of cyclin B1 controls mitotic entry after DNA damage [J].
Jin, P ;
Hardy, S ;
Morgan, DO .
JOURNAL OF CELL BIOLOGY, 1998, 141 (04) :875-885
[25]   Human and yeast Cdk-activating kinases (CAKs) display distinct substrate specificities [J].
Kaldis, P ;
Russo, AA ;
Chou, HS ;
Pavletich, NP ;
Solomon, MJ .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (09) :2545-2560
[26]  
LEVEDAKOU EN, 1995, CANCER RES, V55, P2500
[27]   DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint [J].
Mikhailov, A ;
Cole, RW ;
Rieder, CL .
CURRENT BIOLOGY, 2002, 12 (21) :1797-1806
[28]   PRINCIPLES OF CDK REGULATION [J].
MORGAN, DO .
NATURE, 1995, 374 (6518) :131-134
[29]   Biological activities and molecular targets of the human papillomavirus E7 oncoprotein [J].
Münger, K ;
Basile, JR ;
Duensing, S ;
Eichten, A ;
Gonzalez, SL ;
Grace, M ;
Zacny, VL .
ONCOGENE, 2001, 20 (54) :7888-7898
[30]   REGULATORY PHOSPHORYLATION OF THE P34CDC2 PROTEIN-KINASE IN VERTEBRATES [J].
NORBURY, C ;
BLOW, J ;
NURSE, P .
EMBO JOURNAL, 1991, 10 (11) :3321-3329